Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.

Charlotte Lindberg, Andreas Hillarp, Jörgen Larsson

Research output: Contribution to journalArticlepeer-review

17 Citations (SciVal)
129 Downloads (Pure)

Abstract

Aims: To investigate if the presence of factor V Leiden has an influence on the prognosis in central retinal vein occlusion (CRVO).

Methods: 166 patients with CRVO were studied retrospectively. They were tested for factor V Leiden using DNA analysis. The presence of the mutation was studied in correlation with the development of neovascular complications 1 year after the thrombotic event.

Results: 56 of 166 patients (34%) developed neovascular complications after 1 year. In the patients who had the studied mutation 11 of 20 (55%) had developed neovascular complications after 1 year, compared to 45 of 146 patients (31%) in the group without factor V Leiden (p=0.04).

Conclusion: The presence of factor V Leiden seems to enhance the risk of developing neovascular complications in CRVO.
Original languageEnglish
Pages (from-to)305-306
JournalBritish Journal of Ophthalmology
Volume87
Issue number3
DOIs
Publication statusPublished - 2003

Subject classification (UKÄ)

  • Ophthalmology
  • Medicinal Chemistry

Fingerprint

Dive into the research topics of 'Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.'. Together they form a unique fingerprint.

Cite this